Alexion Pharma (ALXN) Reports Presence of Type II PNH Cells Correlated with Thrombocytopenia
Tweet Send to a Friend
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced presentation of data showing that the presence of Type II paroxysmal nocturnal hemoglobinuria ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
